These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 9212649

  • 1. An unusual clinical course after mole evacuation: a case report.
    Okamoto T, Nakanishi T, Nomura S, Goto S, Sakaida H, Tomoda Y.
    Nagoya J Med Sci; 1997 Mar; 60(1-2):49-52. PubMed ID: 9212649
    [Abstract] [Full Text] [Related]

  • 2. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 3. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB, Granai CO, Ball HG, Curry SL.
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [Abstract] [Full Text] [Related]

  • 4. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
    Kamariah K, Satgunasingam N, Nasri NM, Ng KY.
    Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
    [Abstract] [Full Text] [Related]

  • 5. Serum relaxin in patients with hydatidiform mole.
    Seki K, Uesato T, Tabei T, Kato K.
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [Abstract] [Full Text] [Related]

  • 6. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 7. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 8. [Molar pregnancy (primary or recurrent?)].
    Ayala A, Aizpuru E, Tovar JM.
    Ginecol Obstet Mex; 1989 Aug; 57():226-8. PubMed ID: 2562106
    [Abstract] [Full Text] [Related]

  • 9. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
    Van Trommel NE, Sweep FC, Ross HA, Massuger LF, Thomas CM.
    Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
    [Abstract] [Full Text] [Related]

  • 10. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [Abstract] [Full Text] [Related]

  • 11. [Partial hydatidiform mole with significantly increased serum HCG levels in the triploidy syndrome].
    Arnholdt H, Elser H, Dörmer P.
    Geburtshilfe Frauenheilkd; 1984 May; 44(5):328-32. PubMed ID: 6565615
    [Abstract] [Full Text] [Related]

  • 12. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
    Kerkmeijer LG, Massuger LF, Ten Kate-Booij MJ, Sweep FC, Thomas CM.
    Obstet Gynecol; 2009 Feb; 113(2 Pt 1):326-31. PubMed ID: 19155902
    [Abstract] [Full Text] [Related]

  • 13. [Spontaneous regression of serum HCG in 18 patients following evacuation of uncomplicated androgenic moles].
    Vejerslev LO, Arends J, Larsen SO.
    Ugeskr Laeger; 1988 Aug 29; 150(35):2081-3. PubMed ID: 3413897
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy.
    Schlaerth JB, Morrow CP, Kletzky OA, Nalick RH, D'Ablaing GA.
    Obstet Gynecol; 1981 Oct 29; 58(4):478-82. PubMed ID: 7279342
    [Abstract] [Full Text] [Related]

  • 15. [Use of sulprostone in the evacuation of molar pregnancies].
    Pinet C, Colau JC.
    Rev Fr Gynecol Obstet; 1991 Jan 29; 86(1):53-5. PubMed ID: 2068488
    [Abstract] [Full Text] [Related]

  • 16. [Changes in serum human chorionic gonadotropin in patients with hydatidiform mole following evacuation].
    Wang X.
    Zhonghua Fu Chan Ke Za Zhi; 1988 Nov 29; 23(6):362-4, 388. PubMed ID: 2854773
    [No Abstract] [Full Text] [Related]

  • 17. Normal human chorionic gonadotropin regression curves in uneventful postmolar patients.
    Kizaki S, Matsui H, Usui H, Shozu M, Hanawa S, Yamamoto E, Kikkawa F.
    J Reprod Med; 2012 Nov 29; 57(5-6):243-8. PubMed ID: 22696820
    [Abstract] [Full Text] [Related]

  • 18. Current management of complete and partial molar pregnancy.
    Goldstein DP, Berkowitz RS.
    J Reprod Med; 1994 Mar 29; 39(3):139-46. PubMed ID: 8035368
    [Abstract] [Full Text] [Related]

  • 19. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW, Cho H, Kim H, Nam EJ, Kim SW, Kim S, Kim YT, Kim JH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan 29; 160(1):100-5. PubMed ID: 22055909
    [Abstract] [Full Text] [Related]

  • 20. New criteria for the diagnosis of gestational trophoblastic disease.
    Romero R, Horgan JG, Kohorn EI, Kadar N, Taylor KJ, Hobbins JC.
    Obstet Gynecol; 1985 Oct 29; 66(4):553-8. PubMed ID: 2995891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.